<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>cancer-associated cachexia &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/cancer-associated-cachexia/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 09:33:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>cancer-associated cachexia &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Disrupting Brain-Liver Signaling Could Halt Fatal Cancer-Related Weight Loss</title>
		<link>https://bioengineer.org/disrupting-brain-liver-signaling-could-halt-fatal-cancer-related-weight-loss/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 11 Aug 2025 18:25:40 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[brain-liver axis]]></category>
		<category><![CDATA[cancer-associated cachexia]]></category>
		<category><![CDATA[clinical oncology innovation]]></category>
		<category><![CDATA[metabolic syndrome treatment]]></category>
		<category><![CDATA[vagus nerve therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/disrupting-brain-liver-signaling-could-halt-fatal-cancer-related-weight-loss/</guid>

					<description><![CDATA[Cancer-associated cachexia is a devastating metabolic syndrome that claims nearly a third of all cancer-related lives, manifesting as severe weight loss accompanied by the depletion of both muscle mass and body fat. Despite its prevalence and profound impact on patient morbidity and mortality, cachexia remains an elusive and largely incurable condition. Recent breakthrough research led [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">255056</post-id>	</item>
	</channel>
</rss>
